NRG GU008

Randomized Phase III Trial Incorporating Apatalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy (INNOVATE) INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy.                                                                                                                                                  .

For additional information, please contact the Research Nurses:

  • Caroline DePiano, RN, MSN; 610-738-2522
  • Susan Metzger, RN, MSN; 610-738-2515 

NRG-GU009

Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*)”   Decipher Score <=0.85 vs Decipher Score >0.85.

For additional information, please contact the Research Nurses:

  • Caroline DePiano, RN, MSN; 610-738-2522
  • Susan Metzger, RN, MSN; 610-738-2515 

NRG-GU010

Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)” Decipher Score <0.40 vs Decipher Score >=0.40.

For additional information, please contact the Research Nurses:

  • Caroline DePiano, RN, MSN; 610-738-2522
  • Susan Metzger, RN, MSN; 610-738-2515 
Share This Page: